Vaccine Court ruled that MMR vaccine does not cause autism
On Feb. 12, 2009, the Vaccine Court ruled that MMR vaccine, when administered with thimerosal-containing vaccines, does not…
FDA approved first genetically engineered animal for production of a recombinant form of human antithrombin
On Feb. 6, 2009, the U.S. Food and Drug Administration (FDA) approved the first genetically engineered animal for…
FDA approved changes in the schedule for administering anthrax vaccine
On Dec. 19, 2008, the Food and Drug Administration (FDA) approved changes in the schedule for administering anthrax…
FDA approved expanded indication for use of Boostrix Tdap vaccine in people ages 10-64 years
On Dec. 4, 2008, the Food and Drug Administration (FDA) approved an expanded age indication for the tetanus…
The U.S. FDA opened its first foreign office in Beijing
On Nov. 19, 2008, the U.S. Food and Drug Administration opened its first foreign office in Beijing to…
Biotechnology | FDA | Life Science News | Polio | Vaccine
FDA approved new DTaP-IPV vaccine (Kinrix) for use in children ages 4-6 years
On Jun. 24, 2008, the U.S. Food and Drug Administration (FDA) licensed a combined diphtheria and tetanus toxoid…
Biotechnology | FDA | Life Science News | Polio | Vaccine
FDA licensed Sanofi Pasteur’s new pediatric combination vaccine, Pentacel
On Jun. 23, 2008, Sanofi Pasteur announced the U.S. Food and Drug Administration had licensed Pentacel, Diphtheria and…
FDA approved Pentacel, a new combination DTaP-IPV-Hib vaccine for use in children 6 wksï¾–4 yrs of age
On Jun. 20, 2008, the FDA approved Pentacel (Sanofi Pasteur), a new combination DTaP-IPV-Hib vaccine for use in…
FDA approved the use of Sanofi Pasteur’s Tenivac tetanus and diphtheria toxoids
On Jun. 5, 2008, the FDA approved the use of Sanofi Pasteur’s Tenivac tetanus and diphtheria toxoids adsorbed…
FDA approved new rotavirus vaccine for use in U.S.
On Apr. 3, 2008, the U.S. Food and Drug Administration (FDA) approved new rotavirus vaccine (Rotarix) for use…
Biotechnology | Disease | FDA | Therapeutics
ZymoGenetics received FDA authorization to manufacture the product Thrombin topical (Recombinant)
On Jan. 17, 2008, ZymoGenetics received U.S. Food and Drug Administration (FDA) authorization to manufacture the product Thrombin…
FDA approved Afluria, a new inactivated influenza vaccine for use in people age 18 years and older
On Sept. 28, 2007, the U.S. Food and Drug Administration (FDA) approved an Australian-made influenza vaccine called Afluria…
The FDA Amendments Act of 2007 reauthorized collection of prescription drug user fees
On Sept. 27, 2007, the FDA Amendments Act of 2007 amended the Federal Food, Drug, and Cosmetic Act…
FDA approved use of FluMist nasal-spray influenza vaccine in children age 2-5 years
On Sept. 20, 2007, the U.S. Food and Drug Administration (FDA) approved use of FluMist nasal-spray influenza vaccine…
The FDA approved Eli Lilly and Company’s osteoporosis drug, Evista, to reduce the risk of invasive breast cancer
On Sept. 14, 2007, the U.S. Food and Drug Administration (FDA) announced it had approved Eli Lilly’s osteoporosis…
OHSU became the first in Oregon to offer a new artificial disk for the neck
On Aug. 2, 2007, Oregon Health and Science University (OHSU) became the state’s only medical center to implant…
FDA approved the H5N1 vaccine, the first vaccine approved for avian flu
On Apr. 17, 2007, Sanofi announced that the U.S. Food and Drug Administration (FDA) had licensed its H5N1…
FDA approved an accelerated dosing schedule for Twinrix (hepatitis A and B vaccine)
On Mar. 28, 2007, the FDA announced that GlaxoSmithKline (King of Prussia, Pennsylvania) received approval for an alternate…
Eli Lilly completed its acquisition of ICOS Corp for $23 billion
On Jan. 29, 2007, Eli Lilly announced it had completed its acqusition of ICOS Corp. for $2.3 billion…
FDA licensed the refrigerator formulation of FluMist
On Jan. 7, 2007, the U.S. Food and Drug Administration (FDA) announced it had approved a refrigerated form…
FDA approved Elelyso (taliglucerase alfa) for long-term enzyme replacement therapy to treat a form of Gaucher disease
In 2007, the FDA approved Elelyso (taliglucerase alfa) for long-term enzyme replacement therapy to treat a form of…
FDA approved trastuzumab for use with other drugs in adjuvant treatment of women with early-stage, node-positive, HER2-overexpressing breast cancer
On Nov. 16, 2006, the U.S. Food and Drug Administration (FDA) approved Genentech’s trastuzumab (Herceptin) for use with…
The FDA approved Gleevec, a drug developed by the OHSU Cancer Institute, for five cancers
On Oct. 19, 2006, the U.S. Food and Drug Administration (FDA) approved the drug, Gleevec developed by Oregon…
ICOS Corp announced agreement to be acquired by Eli Lilly and Company
On Oct. 18, 2006, ICOS announced it had signed an agreement to be acquired by Eli Lilly and…
The Biomarkers Consortium was founded
On Oct. 5, 2006, the Foundation for the National Institutes of Health, NIH, FDA, and the Pharmaceutical Research…
Eli Lilly and Company’s Gemzar was approved for use in the treatment of women living with recurrent ovarian cancer
On Jul. 17, 2006, Eli Lilly and Company’s Gemzar was approved for use in the treatment of women…
Genentech drug Lucentisï¾™ (ranibizumab injection) was approved
On Jun. 30, 2006, Genentech drug Lucentisï¾™ (ranibizumab injection) was approved by the FDA for the treatment of…
The FDA approved the vaccine Gardasil for HPV
On Jun. 8, 2006, the FDA approved the vaccine Gardasil, which protects against persistent infection by the two…
Zostavax was approved by the FDA to prevent shingles (herpes zoster) in individuals 60 years of age and older
On May 25, 2006, Zostavax, manufactured by Merck & Co. of Whitehouse Station, New Jersey, was approved by…
VariZIG became available under an IND Expanded Access Protocol
On Feb. 24, 2006, the Advisory Committee on Immunization Practices (ACIP) was informed by the only U.S.-licensed manufacturer…